PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Jencycla™ | 0.35mg |
 |
28 x 3 |
68180-0877-73 |
Ortho-Micronor® |
AB2 |
Oral Contraceptive |
| Imipramine Pamoate Capsules | 75mg |
 |
30 |
68180-314-06 |
Tofranil-PM® |
AB |
Antidepressant |
| Ibuprofen and Famotidine Tablets | 800mg/ 26.6mg |
 |
90 |
70748-312-09 |
Duexis® |
AB |
NSaID |
| Hydrocortisone Valerate Cream USP | 0.2% |
 |
15 g |
68180-954-01 |
Westcort® |
AB |
Anti-inflammatory |
| Hydrocortisone Butyrate Lotion | 0.1% |
|
59 mL |
68180-951-01 |
Locoid® |
AB |
Corticosteroid |
| GaviLyte™ – G | 236-5.86-2.97-6.74-22.74 gm |
|
4 L |
43386-090-19 |
GoLYTELY® |
AA |
Hyperosmotic |
| GaviLyte™ – C | 240 -5.84-2.98-6.72-22.72gm |
|
4 L |
43386-060-19 |
Colyte® |
AA |
Hyperosmotic |
| GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
 |
238g |
43386-312-14 |
MiraLAX® |
AA |
Laxative |
| Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| Fyavolv™ | 0.5mg/0.0025mg |
|
28 x 3 |
68180-827-09 |
FemHRT® |
AB |
Hormone Replacement Therapy |
| Fosaprepitant Dimeglumine for Injection | 150mg |
|
5mL single-dose vial |
68180-690-01 |
Emend® |
AP |
Antiemetic |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
